Brain Tumor Detection and Classification from MRI Images

A brain tumor is detected and classified by biopsy that is conducted after the brain surgery. Advancement in technology and machine learning techniques could help radiologists in the diagnosis of tumors without any invasive measures. We utilized a deep learning-based approach to detect and classify the tumor into Meningioma, Glioma, Pituitary tumors. We used registration and segmentation-based skull stripping mechanism to remove the skull from the MRI images and the grab cut method to verify whether the skull stripped MRI masks retained the features of the tumor for accurate classification. In this research, we proposed a transfer learning based approach in conjunction with discriminative learning rates to perform the classification of brain tumors. The data set used is a 3064 T MRI images dataset that contains T1 flair MRI images. We achieved a classification accuracy of 98.83%, 96.26%, and 95.18% for training, validation, and test sets and an F1 score of 0.96 on the T1 Flair MRI dataset

Machine Learning Algorithm for Early Detection and Analysis of Brain Tumors Using MRI Images

Among the human body's organs, the brain is the most delicate and specialized. It is proven that after the heart stops then also brain death occurs within 3 to 5 minutes of death or within 3 to 5 minutes of loss of oxygen supply. A brain tumor is a life-threatening disease that can be detected at any age from an infant to an old person. Though a lot of people did research in the detection and analysis of a tumor, but then also detecting tumors at the early phase is still a much more arduous field in the biomedical study. This paper focuses on the comparative study of various existing algorithms in this field. This paper addresses the challenges and some issues in MRI brain tumor detection which are also addressed in this research

Advanced Computational Methods for Oncological Image Analysis

[Cancer is the second most common cause of death worldwide and encompasses highly variable clinical and biological scenarios. Some of the current clinical challenges are (i) early diagnosis of the disease and (ii) precision medicine, which allows for treatments targeted to specific clinical cases. The ultimate goal is to optimize the clinical workflow by combining accurate diagnosis with the most suitable therapies. Toward this, large-scale machine learning research can define associations among clinical, imaging, and multi-omics studies, making it possible to provide reliable diagnostic and prognostic biomarkers for precision oncology. Such reliable computer-assisted methods (i.e., artificial intelligence) together with clinicians’ unique knowledge can be used to properly handle typical issues in evaluation/quantification procedures (i.e., operator dependence and time-consuming tasks). These technical advances can significantly improve result repeatability in disease diagnosis and guide toward appropriate cancer care. Indeed, the need to apply machine learning and computational intelligence techniques has steadily increased to effectively perform image processing operations—such as segmentation, co-registration, classification, and dimensionality reduction—and multi-omics data integration.

2D Encoding Convolution Neural Network Algorithm for Brain Tumour Prediction

In contemporary times, biomedical imaging plays a pivotal role in addressing various patient-related concerns.  Brain imaging, particularly through techniques like MRI, offers valuable insights crucial for surgical procedures, radiotherapy, treatment planning, and stereotactic neurosurgery. To facilitate the accurate identification of cancerous cells within the brain using MRI, deep learning and image classification techniques have been deployed. These technologies have paved the way for the development of automated tumor detection methods, which not only save valuable time for radiologists but also consistently deliver proven levels of accuracy. In contrast, the conventional approach to defect detection in magnetic resonance brain images relies on manual human inspection, a method rendered impractical due to the sheer volume of data This paper outlines an approach aimed at detecting and classifying brain tumors within patient MRI images. Additionally, it conducts a performance comparison of Convolutional Neural Network (CNN) models in this context

Improving Patch-Based Convolutional Neural Networks for MRI Brain Tumor Segmentation by Leveraging Location Information.

The manual brain tumor annotation process is time consuming and resource consuming, therefore, an automated and accurate brain tumor segmentation tool is greatly in demand. In this paper, we introduce a novel method to integrate location information with the state-of-the-art patch-based neural networks for brain tumor segmentation. This is motivated by the observation that lesions are not uniformly distributed across different brain parcellation regions and that a locality-sensitive segmentation is likely to obtain better segmentation accuracy. Toward this, we use an existing brain parcellation atlas in the Montreal Neurological Institute (MNI) space and map this atlas to the individual subject data. This mapped atlas in the subject data space is integrated with structural Magnetic Resonance (MR) imaging data, and patch-based neural networks, including 3D U-Net and DeepMedic, are trained to classify the different brain lesions. Multiple state-of-the-art neural networks are trained and integrated with XGBoost fusion in the proposed two-level ensemble method. The first level reduces the uncertainty of the same type of models with different seed initializations, and the second level leverages the advantages of different types of neural network models. The proposed location information fusion method improves the segmentation performance of state-of-the-art networks including 3D U-Net and DeepMedic. Our proposed ensemble also achieves better segmentation performance compared to the state-of-the-art networks in BraTS 2017 and rivals state-of-the-art networks in BraTS 2018. Detailed results are provided on the public multimodal brain tumor segmentation (BraTS) benchmarks